Biosurfit Company

Biosurfit develops breakthrough technologies that enable fast, precise and affordable blood analysis at the point of care.
Technology: Genetic Test & Molecular Diagnostics
Industry: Deep Diagnostics
Headquarters: Lisbon, Lisboa, Portugal
Founded Date: 01.01.2006
Employees Number: 51-100
Funding Status: Early Stage Venture
Investors Number: 4
Total Funding: €10M
Estimated Revenue: $10M to $50M
Last Funding Type: Series A

Visit Website
Register and Claim Ownership